468 related articles for article (PubMed ID: 28750141)
41. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC
Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058
[TBL] [Abstract][Full Text] [Related]
42. Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies.
Mair RD; Valenzuela A; Ha NB; Ayoub WS; Daugherty T; Lutchman GA; Garcia G; Ahmed A; Nguyen MH
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1412-7. PubMed ID: 22902757
[TBL] [Abstract][Full Text] [Related]
43. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
[TBL] [Abstract][Full Text] [Related]
44. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
[TBL] [Abstract][Full Text] [Related]
45. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
Elzouki AN; Eriksson S
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
[TBL] [Abstract][Full Text] [Related]
46. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011.
Di Benedetto N; Peralta M; Alvarez E; Schroder MT; Estepo C; Paz S; Fainboim H
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):38-44. PubMed ID: 24378264
[TBL] [Abstract][Full Text] [Related]
47. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
[TBL] [Abstract][Full Text] [Related]
49. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
Stuart KE; Anand AJ; Jenkins RL
Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
[TBL] [Abstract][Full Text] [Related]
50. Hepatocellular carcinoma in liver cirrhosis. A prospective study.
Imberti D; Fornari F; Sbolli G; Buscarini E; Squassante L; Buscarini L
Scand J Gastroenterol; 1993 Jun; 28(6):540-4. PubMed ID: 7686686
[TBL] [Abstract][Full Text] [Related]
51. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
52. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.
Aleman S; Rahbin N; Weiland O; Davidsdottir L; Hedenstierna M; Rose N; Verbaan H; Stål P; Carlsson T; Norrgren H; Ekbom A; Granath F; Hultcrantz R
Clin Infect Dis; 2013 Jul; 57(2):230-6. PubMed ID: 23616492
[TBL] [Abstract][Full Text] [Related]
53. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
[TBL] [Abstract][Full Text] [Related]
54. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.
Khalaf N; Ying J; Mittal S; Temple S; Kanwal F; Davila J; El-Serag HB
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):273-281.e1. PubMed ID: 27521507
[TBL] [Abstract][Full Text] [Related]
55. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
[TBL] [Abstract][Full Text] [Related]
56. Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India.
Paul SB; Sreenivas V; Gulati MS; Madan K; Gupta AK; Mukhopadhyay S; Panda SK; Acharya SK
Indian J Gastroenterol; 2007; 26(6):274-8. PubMed ID: 18431010
[TBL] [Abstract][Full Text] [Related]
57. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Wong GL; Chan HL; Tse YK; Chan HY; Tse CH; Lo AO; Wong VW
Hepatology; 2014 Mar; 59(3):986-95. PubMed ID: 24123097
[TBL] [Abstract][Full Text] [Related]
58. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
59. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
60. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study.
Fu SC; Huang YW; Wang TC; Hu JT; Chen DS; Yang SS
Aliment Pharmacol Ther; 2015 Jun; 41(11):1200-9. PubMed ID: 25846548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
